Skip to content
healthcare.dev

AMJEVITA

NDC 72511-399, adalimumab-atto, injection, from Amgen USA Inc..

Product NDC
72511-399
Status
Listed
Labeler
Amgen USA Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761024
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72511-399 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB20 mg/.2mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
72511-399-01725110399011 SYRINGE in 1 CARTON (72511-399-01) / .2 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b7178e36-6787-45ab-8fee-be59bc6a4aa4

Use it

Look up 72511-399 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72511-399 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72511-399. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.